Pharmaceutical Training International - Home is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Dissolution Testing

9 - 10 November 2020

Agenda

Dissolution testing is crucial in the development and manufacture of  small molecules. The data obtained during development supports formulation, equivalence and quality decisions. Due to its importance dissolution testing poses a major challenge to the pharmaceutical and generics industries both in terms of method development and regulatory compliance. 
 
This two-day interactive training course will explain the history, benefits, importance and role of dissolution testing in drug development today. Using practical examples and case studies throughout, you will gain a thorough understanding of setting and establishing specifications for optimum dissolution testing. 

This course is also available for studying online, check website for dates>>

  • Gain a practical introduction to the intricacies of dissolution testing with an emphasis on problems and problem solving
  • Select optimum test conditions and method development
  • Ensure your test methods are properly validated
  • Enhance the dissolution rate and bioavailability of your compound
  • Clarify the theory and regulatory aspects involved in developing IVIVC models

Eric Beyssac

Eric Beyssac received a Master’s in Pharmacy and a Ph.D. degree in Pharmaceutical Technology, from the Faculty of Pharmacy, Clermont-Ferrand (France), where he is currently a Professor. He was an invited Professor at the Faculty of Pharmacy of Université Lavalin Québec from 2000 to 2002 and is still Associate Professor at this university. He is currently co-director of the research group CIDAM "Conception, Ingénierie et Développement de l'Alimentet du Medicament" (Conception, Engineering and Development of Food and Drugs). He has authored more than 35 publications in various national and international journals. His research interests include the following: In vitro in vivo correlations, sustained release drug dosage form development, and in vitro dissolution.

This course is designed for professionals working in the following areas:

  • Regulatory Affairs
  • Pharmaceutical Development
  • Analytical Development
  • Project Management
  • Quality Control
  • Quality Assurance

Specifications for Small Molecule Drug Products Webinar

Led by Dr Mark Powell, a Fellow of the Royal Society of Chemistry (RSC) with over 25 years’ experience as a senior analytical chemist. In 2013, Mark set up Mark Powell Scientific, a company that offers training and consultancy services in analytical chemistry.

The webinar will cover: 
• Regulatory guidance (ICH, FDA, EMA) 
• Tests appropriate to different dosage forms 
• Dissolution specifications for immediate-release, modified-release and extended-release drug products 
• Dissolution specifications in the context of the biopharmaceutical classification system 
• Control of polymorphism, enantiomeric purity, drug-related impurities and microbiological contamination 
• Specifications for combination drug products 
• The role of specifications in maximizing drug product stability

IVIVC - A Way to Speed up Development Using Dissolution as a Surrogate Tool.

Led by Jean-Michel Cardot, course leader for Practical Solutions for Establishing IVIVC and Bioavailability and Bioequivalence.
In 30 minutes, this webinar explores how to optimise IVIVC using your dissolution data.

Topics covered:

Basis of IVIVC
Why IVIVC and dissolution are important
Use in development: interest and limitations
Optimisation of formulation based on IVIVC
Conclusions and Q&A session

You may also be interested in...